Nkarta to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in three upcoming investor conferences:

Cowen Annual Health Care ConferenceMarch 6, 20249:10 a.m. ET – industry panel discussion

Leerink Partners Global Biopharma ConferenceMarch 11, 202412:00 p.m. ET – fireside chat

H.C. Wainwright Annual Cell Therapy Virtual ConferenceMarch 26, 20242:00 p.m. ET – fireside chat

A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:Greg MannNkarta, Inc.[email protected]

You May Also Be Interested In

• Seafarer Exploration Enters Agreement With Tom McReynolds to Evaluate Known Shipwreck Site Near Naples
• WillScot Named Presenting Paddock Sponsor for Inaugural Freedom 250 Grand Prix on the National Mall
• Snail Games Unveils Gamescom 2026 Lineup Headlined by Upcoming AAA Title